指南与共识呼吸危重症与机械通气

接受造血细胞移植的成人使用体外膜氧合:国际专家声明

Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation: an international expert statement.
指南 / 共识 · Lancet Respir Med · 2023-03-13

欧洲重症医学会、体外生命支持组织与国际ECMO网络针对接受造血细胞移植(HCT)的成人患者使用体外膜氧合(ECMO)制定专家共识声明。指导委员会检索ECMO、HCT及免疫效应细胞治疗相关文献,采用Quaker共识法与RAND/UCLA适宜性方法由国际专家组投票,共起草36条陈述,首轮投票后33条获强共识,最终33条强共识、3条弱共识。该文件旨在指导重症与血液科医生决策ECMO候选资格。

要点

  • HCT后难治性呼吸或心衰患者可考虑ECMO,但需按专家共识评估候选资格。
  • 共识共36条陈述,最终33条强共识、3条弱共识。
  • 声明可作为ECMO选择标准与床旁管理的未来研究基础。

核心结论

  • 该国际专家共识声明可为接受HCT的成人患者ECMO候选资格决策提供指导,并作为未来研究基础。

研究设计与样本

  • 由欧洲重症医学会、体外生命支持组织与国际ECMO网络制定专家共识声明。
  • 指导委员会检索ECMO、HCT及免疫效应细胞治疗相关文献,采用Quaker共识法形成意见陈述。
  • 国际专家组按RAND/UCLA适宜性方法投票,并遵循AGREE规范准备文件。

主要发现

  • 指导委员会共起草36条陈述,首轮投票后33条获强共识。
  • 剩余3条经指导委员会与专家组全体讨论修改后再次投票。
  • 最终33条获强共识、3条获弱共识。

关键数值与推荐

  • 36条陈述中33条首轮投票即达强共识,最终强共识33条、弱共识3条。

临床怎么用

  • 可用于指导重症科与血液科医生在HCT成人患者中决策ECMO候选资格。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Combined advances in haematopoietic cell transplantation (HCT) and intensive care management have improved the survival of patients with haematological malignancies admitted to the intensive care unit. In cases of refractory respiratory failure or refractory cardiac failure, these advances have led to a renewed interest in advanced life support therapies, such as extracorporeal membrane oxygenation (ECMO), previously considered inappropriate for these patients due to their poor prognosis. Given the scarcity of evidence-based guidelines on the use of ECMO in patients receiving HCT and the need to provide equitable and sustainable access to ECMO, the European Society of Intensive Care Medicine, the Extracorporeal Life Support Organization, and the International ECMO Network aimed to develop an expert consensus statement on the use of ECMO in adult patients receiving HCT. A steering committee with expertise in ECMO and HCT searched the literature for relevant articles on ECMO, HCT, and immune effector cell therapy, and developed opinion statements through discussions following a Quaker-based consensus approach. An international panel of experts was convened to vote on these expert opinion statements following the Research and Development/University of California, Los Angeles Appropriateness Method. The Appraisal of Guidelines for Research and Evaluation statement was followed to prepare this Position Paper. 36 statements were drafted by the steering committee, 33 of which reached strong agreement after the first voting round. The remaining three statements were discussed by all members of the steering committee and expert panel, and rephrased before an additional round of voting. At the conclusion of the process, 33 statements received strong agreement and three weak agreement. This Position Paper could help to guide intensivists and haematologists during the difficult decision-making process regarding ECMO candidacy in adult patients receiving HCT. The statements could also serve as a basis for future research focused on ECMO selection criteria and bedside management.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Di Nardo M, MacLaren G, Schellongowski P, et al. Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation: an international expert statement. Lancet Respir Med. 2023. PMID: 36924784. doi:10.1016/S2213-2600(22)00535-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。